In 2006, the first vaccine against human papillomavirus (HPV) infection, Gardasil (Merck Frosst), was approved for use in Canada. A second vaccine, Cervarix (GlaxoSmith Kline), is currently undergoing regulatory review by Health Canada. Both vaccines are designed with the goal of preventing cervical
No takes yet. Share an insight, caveat, or question.
Dawar et al. (2007) studied this question.